Hexagon Nutrition reported a 17.7% revenue increase to ₹382.63 crore and a 56% net profit jump to ₹37.94 crore for FY26. Auditors highlighted going concern risks for foreign subsidiaries, but management pledged support.
Hexagon Nutrition FY2026 Financials Show Strong Growth Amidst Auditor Concerns
Hexagon Nutrition reported consolidated revenue from operations of ₹382.63 crore for the fiscal year ended March 31, 2026, a 17.7% increase from ₹324.93 crore in FY2025. Net profit for the period rose significantly by 56%, reaching ₹37.94 crore compared to ₹24.31 crore in the previous year.
Reader Takeaway: Robust profit growth shines, but foreign subsidiary risks require close monitoring.
What just happened
Hexagon Nutrition announced its consolidated financial results for the fiscal year 2026. The company saw a substantial year-on-year increase in both its top line and bottom line. Revenue from operations grew to ₹382.63 crore from ₹324.93 crore, and net profit jumped to ₹37.94 crore from ₹24.31 crore.
Why this matters
These results indicate strong operational performance and improving profitability for Hexagon Nutrition. The revenue growth suggests increasing demand for its nutritional products, while the significant profit increase highlights effective cost management or improved margins. However, auditor comments on foreign subsidiaries introduce a note of caution.
The backstory
The company completed its Initial Public Offering (IPO) via a 100% offer for sale on June 12, 2026, meaning no fresh capital was raised by the company. Additionally, Compulsorily Convertible Preference Shares (CCPS) were converted into equity shares on April 20, 2026, impacting the company's capital structure.
What changes now
With the IPO completed, Hexagon Nutrition is now a publicly listed entity. Investors will closely scrutinize its performance against market expectations. Management's commitment to supporting foreign subsidiaries financially will be crucial in mitigating the 'going concern' risks highlighted by the auditors.
Risks to watch
Auditors have expressed a material uncertainty regarding the going concern status of Hexagon Nutrition's subsidiaries in South Africa and Uzbekistan due to accumulated losses. While management has pledged unconditional financial support and these subsidiaries reported profits in FY2026, their long-term viability remains a key risk.
Peer comparison
(No specific peer comparison data was provided in the filing.)
Context metrics (time-bound)
- Revenue Growth: 17.7% year-on-year increase in FY2026.
- Net Profit Growth: 56% year-on-year increase in FY2026.
- IPO Date: June 12, 2026.
- CCPS Conversion: April 20, 2026.
What to track next
Investors should monitor the turnaround progress of the South African and Uzbek subsidiaries and the continued financial support provided by the parent company. Consistent revenue and profit growth in the core business will also be key indicators.
